Cite

HARVARD Citation

    Pinato, D. et al. (2021). Therapeutic targeting of VEGFR2 in HBV-associated hepatocellular carcinoma. Lancet gastroenterology and hepatology. pp. 515-516. [Online]. 
  
Back to record